KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	156,184	166,982	257,943	233,403	529,520	242,129
Market Cap Growth	-15.69%	-35.26%	10.51%	-55.92%	118.69%	-
Enterprise Value	163,426	151,067	248,815	222,946	528,191	235,248
Last Close Price	14320.00	15310.00	23572.66	21282.30	48172.24	22004.51
PE Ratio	107.92	44.04	3079.40	-	83.15	76.65
Forward PE	-	82.10	82.10	82.10	112.13	39.78
PS Ratio	1.83	2.05	3.10	2.88	6.65	3.39
PB Ratio	2.20	2.34	3.76	3.90	9.21	5.21
P/TBV Ratio	2.32	2.48	3.96	4.10	9.72	5.50
P/FCF Ratio	-	34.81	78.44	40.14	114.12	-
P/OCF Ratio	41.19	20.75	53.52	28.19	73.62	-
EV/Sales Ratio	1.92	1.86	2.99	2.75	6.64	3.29
EV/EBITDA Ratio	19.13	17.01	28.75	26.02	71.46	34.47
EV/EBIT Ratio	29.56	24.82	42.60	36.03	105.34	51.10
EV/FCF Ratio	-9.10	31.49	75.67	38.34	113.83	-
Debt / Equity Ratio	0.53	0.32	0.51	0.91	0.94	0.30
Debt / EBITDA Ratio	5.42	2.58	4.03	6.38	7.27	2.04
Debt / FCF Ratio	-	4.77	10.60	9.40	11.58	-
Asset Turnover	0.70	0.70	0.66	0.62	0.76	0.97
Inventory Turnover	2.38	2.46	2.59	2.67	2.40	2.30
Quick Ratio	1.16	2.76	1.89	1.14	3.13	1.13
Current Ratio	1.71	3.81	2.56	1.41	3.81	1.79
Return on Equity (ROE)	2.05%	5.42%	0.13%	-1.91%	12.25%	8.64%
Return on Assets (ROA)	2.01%	3.26%	2.89%	2.97%	2.97%	3.89%
Return on Capital (ROIC)	2.36%	3.85%	3.35%	3.43%	3.65%	5.53%
Return on Capital Employed (ROCE)	4.50%	6.50%	6.60%	10.10%	4.80%	9.10%
Earnings Yield	0.93%	2.27%	0.03%	-0.48%	1.20%	1.31%
FCF Yield	-11.49%	2.87%	1.27%	2.49%	0.88%	-1.18%
Payout Ratio	37.65%	14.38%	651.04%	-	8.56%	13.91%
Buyback Yield / Dilution	-16.03%	-15.33%	3.63%	1.22%	-12.80%	-10.95%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.